LAG3 and non-small cell lung carcinoma: Some works on early stage radically resected NSCLC have previously associated tumor-infiltrating lymphocytes (TILs) and immune checkpoint expression, such as programmed death ligand 1 (PD-L1) and lymphocyte activation gene 3 (LAG-3), with patient’s prognosis (5–10).